Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites by unknown
Signal Transduction in Host Cells by a 
Glycosylphosphatidyllnositol  Toxin of Malaria 
Parasites 
By Louis Schofield and Fiona Hackett 
From the National Institute for Medical Research, London NW7 1AA,  United Kingdom 
Summary 
In this study, we have identified a dominant glycolipid toxin of Plasmodium fakiparum.  It is a 
glycosylphosphatidylinositol (GPI). The parasite GPI moiety, free or associated with protein, 
induces tumor necrosis factor and interleukin I production by macrophages and regulates glucose 
metabolism in adipocytes. Deacylation with specific pbospholipases abolishes cytokine induction, 
as do inhibitors of protein kinase C. When administered to mice in vivo the parasite GPI induces 
cytokine release, a transient pyrexia,  and hypoglycemia. When administered with sensitizing 
agents it can elicit a profound and lethal cachexia. Thus, the GPI of Plasraodium is a potent glycolipid 
toxin that may be responsible for a novel pathogenic process, exerting pleiotropic effects on a 
variety of host cells by substituting for the endogenous GPI-based second messenger/signal 
transduction pathways. Antibody to the GPI inhibits these toxic activities, suggesting a rational 
basis for the development of an antiglycolipid vaccine against malaria. 
M 
alaria has been recognized as a distinct disease since 
Vedic times because infection is characterized by peri- 
odic fevers (1). In Plasmodiumfakiparum and P. malariae  infec- 
tion (tertian and quartan malaria,  respectively),  these fevers 
arise  through the  synchronous release of parasite-derived 
"toxins" during the 48- or 72-h blood-stage developmental 
cycle (2).  These in turn cause  the release of endogenous 
pyrogens such as TNF and IL-1, which mediate the febrile 
response by acting upon the hypothalamus. In addition to 
involvement in this classical picture of uncomplicated din- 
ical malaria in nonimmunes, there is evidence of a role for 
TNF in a wider spectrum of malaria-associated  disease, in- 
cluding severe clinical malaria, various malarial pathologies, 
and even death due to the infection. A recent case-control 
study has shown a strong correlation between TNF and Ibl 
levels in the sera of malarious individuals and the severity 
of the  disease. Compared  with  clinically  uncomplicated 
malaria,  plasma TNF levels were twice as high in cerebral 
malaria  survivors  and 10 times elevated in those that died 
of the disease (3). Circulating TNF can also be detected at 
high levels in the sera of mice with lethal rodent malaria, 
the concentration increasing with parasitemia  (4).  In ex- 
perimental models,  administration  of recombinant  TNF 
mimics a variety of the pathologies often associated with more 
severe malarial  disease. These include anemia, hypertrigly- 
ceridaemia, hypotension, accumulation of nentrophils in the 
pulmonary vasculature, diffuse intravascular coaguhtion, and 
abortion (5)+ TNF may also contribute to cerebral malaria 
by upregulating expression of the endothelial cell marker in- 
tercdlular adhesion molecule 1, recognized by mature para- 
sites during cerebral sequestration (6). Finally, the adminis- 
tration in vivo of specific neutralizing antibodies against TNF 
affords some protection to mice infected with lethal malaria 
(7). Although other cytokines and agents may well influence 
pathology and the clinical outcome of infection, it appears 
from this circumstantial and direct evidence that ese~ss  produc- 
tion of TNF in response to parasite toxins contributes to se- 
vere pathology and death in both rodent and human infections. 
African trypanosomiasis shares certain pathophysiological 
features with malaria. It too is in part an immunopatholog- 
ical disease, or a form of systemic inflammation with a marked 
cachectic component. High levels of circulating monokines 
are found in association with the infection (8), and many of 
the syndromes that occur during the acute disease can also 
be induced experimentally by the administration of the en- 
dogenous pyrogens TNF and IL-1 (9). 
Cocultivation studies have shown that the rodent malarias 
P. berghei and P. yoelii can induce TNF formation from mac- 
rophages in vitro (10). Furthermore, boiled extracts of these 
parasites are able to induce high levels of TNF in the sera 
of mice sensitized with bacterial  agents (11). Beyond these 
studies, however, the specific  biochemical identity of the postu- 
lated malarial toxins is unknown. In this study, we demon- 
strate that the glycosylphosphatidylinositol (GPI) t moieties 
t Abbreviations used in this paper:. GPI, glycosylphosphatidylinositol;  PC- 
PI.C,  phosphatidylcholine-specific  phospholipase  C;  PI-PLC,  phospha- 
tidylinositol-specific phospholipase C. 
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have the properties of such toxins, as the highly purified GPIs 
free of associated proteins are able to induce high levels of 
TNF  and IL-1 from macrophages,  and cause  pyrexia and 
cachexia in vivo. The GPI moieties are also insulin mimetic, 
regulating glucose metabolism by adipocytes and inducing 
profound hypoglycaemia in vivo. We propose therefore that 
parasite GPI molecules exert a pleiotropic influence on a va- 
riety of host cells when released during merogony or cell death, 
by substituting for the endogenous GPI-based second mes- 
senger/signal transduction pathways of the host. 
Materials and Methods 
Rea&ents. Phospholipase  A2 from Crotalas  atrox  and  bee  venom 
(E.C. 3.1.1.4.) were obtained from Sigma Chemical Co. (St. Louis, 
MO) and Boehringer Mannheim Biochemicals  (Mannheim, Ger- 
many), respectively. Phosphatidycholine-specitic  phospholipase C 
(Bacillus cereus) (E.C. 3,1.4.3.) and pronase were also obtained from 
both sources. Phosphatidylinositol-specific  phospholipase C (PI- 
PLC)  was  obtained  from  Boehringer  Mannheim Biochemicals.  Pro- 
tein  G--Sepharose,  Con A-Sepharose,  polymyxin  B-Sepharose,  Poly- 
myxin  13,  dithiothreitol,  n-octylthioglucopyranoside  (n-otg),  formic 
acid, TCA,  1,10-phenanthroline, PMSF, p-tosyl-L-lysine-chloro- 
methylketone (TICK), N-tosyl-t-phenylahninechloromethytketone 
(TPCK), p-chloromercuriphenylsulphonic acid (p-CMPS), apro- 
tinin, leupeptin, pepstatin, iodoacetamide, and n-ethyl-maleimide 
(NEM) were obtained from Sigma Chemical Co. Sephadex was 
from.Pharmacia Fine Chemicals (Uppsala, Sweden). Analytical or 
HPLC-grade toluene, chloroform, diethyl ether, ethanol, methanol, 
and water were obtained from BDH and Waters Associates (UK). 
Recombinant murine TNF was from Genentech. mAb TN3.19.12 
against routine TNF was the kind gift of  Dr. Schreiber (University 
of Missouri) mAbs 111.4 and 113.1 against the MSlXl (COOH- 
terminal domain) and MSP-2 surface  antigens of  P..fi/apamm,  respec- 
tively, were the kind gift of Dr. Tony Holder (NIMR). 
Animals.  Adult  CBA/Ca,  BALB/c, and  C3H/HeJ  (LPS- 
hyporesponsive) mice  were bred within the specific  pathogen-free 
National Institute for Medical Research Animal Facility. 
Malaria Parasite Culture.  The T9.94 line of P. falcipamm  was 
grown in vitro by the method of ~rager and Jensen (12). Syn- 
chronous development  of  parasites was maintained  by a modification 
(13) of the sorbitol method of Lambros and Vanderberg (14). For 
the biosynthetic hbding of parasite proteins, [SH]myristic  add (50 
Ci/mmol) or [3H]palmitic acid (50 Ci/mmnl; Amersham Inter- 
national, Amersham, UK) was conjugated to defatted BSA in a 
molar ratio of 1:1 and added at a final specific  activity of 10 ~tCi/ml, 
to RPMI 1640 cultures of 101~  parasites at the late trophozoite 
stage for 8-12 h. Washed  parasites were harvested  by 0.05  % Saponin 
lysis and centrifugation in the cold at 15,000 g for 20 min, fol- 
lowed by storage at  -70~ 
Purification of the 195-kD MSP-I and 56-kD MSP-2 Ana'gens.  La- 
beled malaria parasites at the mid to hte schizont stage were lysed 
in 0.05% Saponin  and centrifuged at 15,000g for 20 min, as above. 
The pellet was extracted in 25 mM n-octyl-thioghcopyranoside 
(n-otg), 1% BSA, 1 mM EI3TA, 0.1 mM EGTA, 1 mM PMSF, 
1 mM TPCK, 0.1 mM TLCK, 5 mM pCMPS, 1/~g/ml pepstatin, 
1 ~tg/ml leupeptin, 1 mM NEM, 150 mM NaC1, 5 mM iodoaceta- 
mide, by sonication on ice. The extract was clarified  by centrifuga- 
tion at 20,000g for 30 rain in the cold, and the supernatant  decanted 
and loaded  onto two immunoafflnlty  columns arranged  in sequence, 
containing  ,vl0  mg mAb 111.4  or 113.1,  each  crosslinked  to  pro- 
tein G-Sepharose by glutaraldehyde (all procedures on ice). The 
protein extract was passed through the column at a rate of 0.3 
ml/min. The cohmns were washed first with with 100 m110 mM 
n-otg, 1% BSA, 300 mM NaCI, followed  by 100 m110 mM n-otg, 
300 mM NaC1. Antigen was eluted from each column with four- 
column volumes of 10 mM n-otg, 200 mM glycine, pH 2.8. The 
pH of the eluate was neutralized with 2 M Tris. The purified pro- 
teins were dialyzed  exhaustively  against 25 mM Tris/HC1, pH 8,5, 
followed by lyophilization under vacuum. Protein concentration 
was determined by the method of  Bradford (15). The proteins were 
reconstituted in a variety of buffers for biochemical analysis and 
in complete RPMI 1640 for use with viable cells. In some cases 
after reconstitution the proteins were further dialyzed against the 
buffer of choice, using dialysis  membrane previously  boiled exhaus- 
tively  in 10 mM EDTA followed  by boiling in 10 changes  of  double- 
distilled water. 
SDS-PAGE.  Parasite extract or purified proteins were boiled 
in reducing or nonreducing samph buffer and subjected to dec. 
trophoresis through a 4.5% stacking gel fotlowed by 7.5 or 10% 
slab separation gels. Proteins were silver stained by the method of 
Oakley et al. (16), or stained with Coomassie brilliant bhe. For 
autoradiography,  gels were fixed in ethanol/acetic acid followed  by 
DMSO and 20% PPO. Western blotting was carried out onto 
nitrocellulose paper via  Tris/glycine/methanol. The paper was 
blocked with 1% BSA and exposed to polyclonal rabbit antisera 
raised against a 195-kD recombinant protein (kind gift of  Dr. Tony 
Holder), followed  by affinity-purified  goat anti-rabbit Ig (~/chain 
specific) conjugated  to alkaliue  phosphatare. After washing the color 
reaction was developed by the addition of substrate. 
Purification of the GPI Anchor.  To purify the intact COOH- 
terminal GPI free of associated protein or peptide fragments, we 
used the protocol developed by Roberts and Rosenberry (17, 18) 
for the purpose of purifying to homogeneity the GPI of acetyl- 
cholinesterase. Initially, to determine the relative  molecular  weight 
of the GPI, purified MSP-1 or MSP-2 were digested for 24 h with 
2.5% (wt/wt) Pronase, at 50~  in 20 mM Sodium  phosphate buffer, 
I  mM Ca  2+, 0.05%  TX-100, followed by addition of 0.25% 
(wt/wt) of fresh pronase and a further overnight incubation. The 
pronase-released GPI fragment was separated  from undigested ma- 
terial by chromatography on a Sephacryl 400 column (1.5  x  80 
cm) in 0.05% TX-100 in 20 mM phosphate buffer, pH 7.0. The 
UV absorbance at 280 nm of the flow-through was monitored 
(Uvicord SII) and recorded by a chart recorder (Rec 102; Phar- 
macia Fine Chemicals), and the elution position of radiolabeled 
peaks was determined  with respect to bhe dextran, protein markers, 
and K2Cr207. Fractions containing the second radioactive peak 
were pooled, lyophilized, reconstituted in 88% formic acid, and 
rechromatographed on a 1-m LH-60 Sephadex  column (1.5 x  100 
cm) in absolute  ethanol/88% formic acid  in the ratio 3:1, over 24 h. 
The UV absorbance of the flow-through was monitored as before 
and the relative molecular weight of the eluted radioactive peaks 
was determined with respect to peptide markers (lysozyme,  14,300 
M~; aprotinin, 6,500 Mr; glucagon, 3,480 M,; gramicidin, 1,850 
Mr). The radioactive fraction was dried down in a Speedvac and 
resuspended  by the addition of the buffer of choice and incubation 
in a sonicating water bath. In subsequent experiments, to purify 
the intact COOH-terminal GPI free  of  both detergent and associated 
protein or peptide fragments for use in vitro and in vivo, purified 
MSP-1 or MSP-2 in 10 mM n-otg were dialyzed against 100 mM 
NHd-ICCh,  5 rnM p-CMPS until free of detergent followed by 
pronase digestion as above without detergent, and extraction in 
butanol. The sample volume was reduced in a Speedvac, followed 
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radioactive fraction was dried down in a Speedvac and resuspended 
by the addition of 5/tl ethanol followed by buffer of choice and 
incubation in a sonicating water bath. 
Stability of the Fatty Acid Linkage to the 195-kD Polypeptide.  0.5 
ml chloroform/methanol was added to an appropriate volume of 
the purified radiolabeled proteins in water to give a ratio of 8:4:3. 
The pH of the aqueous phase was adjusted to 3 by the addition 
of HCI or glacial acetic acid. The mixture  was vortexed and 
microfuged, the organic and aqueous phases removed, and the 
aqueous phase subject to two further washes with chloroform 
presaturated with water and methanol. Both aqueous and organic 
phases were assayed  for tritium decay. In further experiments, la- 
beled proteins were incubated in 50 mM NaOH or 50 ram NaC1 
in 90% ethanol for 20 min. The samples were divided into two 
aliquots, followed by the addition of acidified  water (pH 2.8) and 
toluene extraction of one-half, and determination of radioactivity 
in the respective organic and aqueous phases. The remaining halves 
of the samples were precipitated in cold ethanol (- 70~  and the 
pellet was dissolved in 100 mM Tris/HC1, pH 8.0. 
Treatment of Purified Lipoproteins with Phospholipase A2.  100- 
1,000 U  of phospholipase Az from C  atrox or bee venom was 
added to various concentrations of the purified lipoproteins in 0.5 
M Tris/HC1, pH 7.5, 15 raM CaClz, 10 mM n-otg at 37~  over- 
night. The samples were split and some aliquots acidified to pH 
3 with HC1 and extracted into toluene, and the radioactivity in 
the organic and aqueous phases was determined. Other aliquots 
were subjected to electrophoresis in SDS-PAGE followed  by transfer 
to nitocellulose and Western blotting with polyvalent rabbit anti- 
MSP-1, to determine the integrity of the protein determinants. Re- 
maining aliquots were dialyzed  extensively  against complete RPMI 
1640 and used in assays of TNF induction. 
Treatment of Purified Lipoproteins with R  cereus Phospholipase C. 
400 U of  R cereus  phospholipase C was added to the purified native 
proteins in 100 mM phosphate buffer, 10 mM n-otg, and incubated 
with vigorous shaking at 37~  overnight. Aliquots of the digested 
material and control incubations in identical buffer without en- 
zyme were removed for extraction with diethyl ether, and the or- 
ganic and aqueous phases measured for tritium decay. Other ali- 
quots of the PC-PLC-digested and control material were analyzed 
by SDS-PAGE, and the remaining material was dialyzed  extensively 
against RPMI 1640 and used in assays in vitro. 
Treatment of Purified Lipotm~teins with PI-PLC.  Staptr2/lococcus 
aureus PI-PLC was added to purified MSP-1 and MSP-2 in 100 mM 
phosphate buffer, 0.5% NP-40, 5 mM dithiothrietol at 37~  over- 
night, followed by acidification  to pH 3 with HCI and extraction 
in diethyl  ether. Organic and aqueous phases were assayed  for tritium 
decay. 
P,~ration of Macrophages,  Mice were inoculated intraperi- 
toneally with 2 ml 4% thioglycollate  medium and the elicited  peri- 
toneal exudate cells were harvested by peritoneal lavage after 4 d, 
in HBSS containing 5 U/ml heparin and 5/tg/ml polymyxin B 
(Sigma Chemical Co.). The cells were washed twice in HBSS and 
numbers determined by hemocytometer counting in Turks' solu- 
tion. Viability was determined by trypan blue exclusion. The cells 
were resuspended in R.PMI 1640 +  10% endotoxin-free FCS to 
a concentration of 2.5  x  106/ml, and 0.1 ml aliquots dispensed 
into the wells of a 96-well plate. The cells were allowed to adhere 
for 3 h at 37~  in 5% CO2 in air, after which an equal volume 
of medium containing 2/~g/ml indomethacin was added. After 
30 rain nonadherent cells were removed by washing with R.PMI 
1640 alone. The cells were then incubated overnight with test and 
control agents in duplicate in RPMI 1640 +  10% endotoxin-free 
FCS, and the culture supematants were harvested for determina- 
tion of TNF levels. 
TNFBioassay.  Samples  to be tested and a recombinant murine 
TNF of known specific  activity were titrated twofold in medium 
containing actinomycin D (5/tg/ml), with a final volume of 100 
/~1, and their TNF levels were determined by measuring percentage 
CytOtoxicity for L929 cells, as described (19). Assays  were performed 
in 96-weU plates, each well receiving 5  x  104 target cells at least 
4 h before addition of samples. All plates contained both positive 
and negative  controls (250 U TNF and medium alone, respectively). 
After overnight incubation at 37~  the wells were washed in PBS, 
methanol fixed, and stained with 1% crystal violet in water. After 
washing with PBS the wells received 33% acetic acid and the ab- 
sorbance at 540 nm was determined in a Titertek Multiscan auto- 
mated ELISA  _re~_der. In our assays  we routindy  observed  dose agree- 
ment between the manufacturers' reported specific  activity of the 
recombinant TNF and the titrated lyric activity against the target 
L929 cells (standard curve). 1 U of  activity is defined  as that which 
causes 50% destruction of target cells, by comparison with the 
standard curve. 
II,1  Capture ELISAs.  IL-1  levels were determined by capture 
of ELISA (Genzyme, Boston, MA). Briefly, a standard curve was 
generated by the titration  of mouse rIL-1, and test and control 
samples were incubated at  37~  for 40 min in 96-well plates 
precoated with monoclonal anti-IL-1, followed by washing and 
probing under the same conditions with biotinylated polyclonal 
anti-IL-1, followed by avidin-peroxidase. After addition and devel- 
opment of substrate, the plates were read by Titertek Multiscan 
automated ELISA reader. 
Glucose Metabolism in Adipocytes.  Adipocytes  were prepared by 
collagenase  digestion from the epidydimal  fat pads of  male Sprague- 
Dawley rats by the method of RodbeR (20). 2.25 x  104 cells were 
resuspended  in polyla'opylene  tubes with test agents in 500 #1Krebs- 
Ringer bicarbonate, 1% BSA, 5 mM [14C]ghcose, pH 7.4, for 2 h 
at 37~  in 5% CO2 in air. This concentration of glucose ensures 
that glucose transport is not rate limiting for oxidation or lipogen- 
esis. Lipoganesis  was measured  by the method of  Moody et al. (21), 
as the incorporation of label into toluene extractable lipids. Glu- 
cose oxidation was measured as the generation of 14COz absorbed 
to hyamine hydroxide (20). 
Results 
Several major antigens of the malaria parasite are covalently 
linked to GPI, including the MSP-1 and MSP-2 antigens on 
the merozoite surface, currently under consideration as vac- 
cine candidates. To investigate the biology of the malarial GPI 
moiety, P.falciparum parasites were metabolically  labeled with 
[3H]myristic or [3H]paknitic acids, and these two proteins 
were affinity purified to homogeneity, by affinity chroma- 
tography against two columns arranged in sequence, each con- 
taining 10 mg of either mAbs 111.4 or 113.1 in the optimal 
steric configuration, obtained by crosslinking the Fc-bound 
mAbs to protein G-Sepharose via glutaraldehyde. The use 
of BSA and high salt in repeated washing of these columns 
served to abolish nonspecific retention of proteins. The duted 
antigens appeared  to be essentially 100% pure as judged by 
the relativdy low levels or absence of contaminating bands 
on SDS-PAGE gels stained by sensitive  silver staining pro- 
tocols, or Coomassie brilliant blue (Fig.  1). Typically, yields 
of ~500/tg to 1.5 mg of each pure malarial protein were 
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to homogenr  (A) Lanes 1-3 shows fractions duted from a monodonal 
111.4 column (anti-MSP-1). Lanes 4 and 5 received a low and high concen- 
tration of molecular mass markers, respectively, (B) Lane 1 shows material 
eluted from a monoclonal 113.1 column (anti-MSP-2). Lane 2 recdved no 
sample and lane 3 received molecular mass markers, as indicated. Both 
gels were stained with Coomassie brilliant blue. 
Figure 2.  A280 Uvicord trace and cpm/fraction after LH-60 purification 
of [3H]fatty acid-labded malarial GPI. After Sephacryl fractionation  of 
a pronase digest of MSP-2, the GPI peak was pooled,  lyophilized, and 
redissolved in 88% formic acid. Ethanol was added to 75%, the samples 
were left at - 70~  for 30 rain, spun in a microfuge, and rechromatographed 
on a 1-m Sephadex LH-60 column equilibrated in ethanol/88% formic 
acid 3:1 for 24 h. Cherenkov counting in scintillation cocktail was under- 
taken on aliquots. Considerable  overhp was observed  between the migrating 
GPI and Triton X-100, as shown by UV absorbance. The peptide stan- 
dards were: lysozyme, 14,300 Mr; aprotinin, 6,500 Mr; glucagon,  3,480 
Mr; gramicidin, 1,850 Mr. The arrows mark the elution position of blue 
dextran  and K2Cr2OT, respectively. 
obtained from 5-10  x  109 fatty add-labded schizonts, as 
determined by the Bradford method using BSA as a stan- 
dard. Assuming 1 mol of GPI/mol of purified protein, the 
specific activity of incorporated [3H]palmitic acid was found 
on  various  occasions  to  range  from  ~1.0  to  1.3  x  104 
cpm/nmol GPI  for  MSP-1 and  from  1.2  to  1.5  x  104 
cpm/nmol GPI for MSP-2. Similar specific activities were ob- 
tained with [3H]myristic  acid. 
After affinity purification and exhaustive dialysis, labeled 
proteins were extracted with chloroform/methanol  followed 
by methand/water-saturated chloroform. 97% of counts re- 
mained in the aqueous phase, indicating that the labd was 
covalently linked to  the protein.  In various preparations, 
washing the proteins in cold acetone containing 5 mM cold 
myristic acid or palmitic acid resulted in the precipitation 
of between 85 and 97% of counts (data not shown). Incuba- 
tion  of both  [3H]myristic  and  [3H]palmitic  add-labded 
malarial proteins with 50 mM NaOH in ethanol for 30 min 
released essentially  all of the counts into the organic phase 
in each case (data not shown), demonstrating that all of the 
label is ester linked to the protein, as previously reported for 
[3Hlmyristic add-labded MSP-1 (22). 
Purification of the COOH-terminal GPI Moiety.  Following 
protocols used to generate the GPI moiety linked to  the 
COOH-terminal amino adds of acetylcholinesterase, bacteri- 
orhodopsin, and the membrane form VSG of Trypanosoma 
bruce/(17, 18, 23), malarial antigens purified to homogeneity 
were dissolved in Triton X-100 and digested extensively with 
pronase, and the digested material was fractionated by mo- 
lecular mass on a Sephacryl S-200 column. During control 
runs with undigested material, 100% of radiolabel appeared 
in the void volume of the column as determined  by exclusion 
of blue dextran of 2  x  106 kD.  After extensive  pronase 
digestion, however, the labd was associated  with a more slowly 
migrating second peak, which was nonethdess dose to the 
void volume. This peak, however, was not composed of neu- 
tral lipids or free fatty acids as it proved impossibh to extract 
into toluene or chloroform (data not shown). A similar frac- 
tionation pattern has been reported for the GPI of acetyl- 
cholinesterase (17). Under these conditions, the hydrophobic 
GPI molecule will migrate in detergent miceUes, giving an 
apparent molecular mass far in excess of the true value. To 
analyze the true molecular mass of the second fraction, and 
to free the sample of Triton X-100 and free peptides, the second 
peak was pooled, lyophilized, and redissolved in 88% formic 
acid.  Ethanol was added to 75%,  the samples were left at 
-70~  for 30 min, spun in a microfuge, and the superna- 
tant rechromatographed under gravity on a 1-m Sephadex 
LH-60 column equilibrated in ethanol/88% formic acid (3:1) 
for 24 h. Percentage recoveries were usually very high, with 
95-100% radiolabded material migrating in a well-resolved 
peak covering 16.9-19.2%  of the specific  elution volume (Fig. 
2). In different determinations the radiolabded peak derived 
from pronase digestion of MSP-2 migrated with an apparent 
molecular mass of 2,950, 3,050, and 3,200 daltons, as com- 
pared with peptide markers. LH-60 has a fractionation range 
from ,,,102 to 104 daltons, and the column was well able to 
resolve the GPI peak from free fatty acids and free amino 
adds.  When aliquots of intact  (pronase-undigested) fatty 
add-hbded MSP-2 were taken up in ethanol/88% formic 
acid and run on the LH-60 column, all proteins and label 
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the lyophilized GPI after Sephacryl fractionation  migrated 
with considerable overlap of the GPI fractions as shown by 
the UV profile. To generate GPI free of contaminating deter- 
gent and peptides for use in vivo and in vitro, the fatty add-la- 
beled proteins  were dialyzed until free of detergent before 
pronase digestion,  and were then extracted in butanol and 
fractionated by LH-60.  The tritium-containing fractions in 
the ,~3-kD peak eluting from the LH-60 column were dried 
down by Speedvac and taken up in 2/~1 ethanol, to which 
was added the aqueous buffer of  choice. As expected, repeated 
extractions in chloroform/methanol failed to release counts 
into the organic phase, but essentially 100% of labeled mate- 
rial could be extracted into butanol. Similar patterns of frac- 
tionation and organic solvent extraction were obtained when 
the GPI was biosynthetically labeled by the incorporation 
of tritium-labeled sugars (data not shown). 
Enzymatic Deacylation of the GPI.  To reproduce the findings 
of previous studies, and to generate deacylated native protein 
for structure/activity studies, we treated the purified, labeled 
MSP-1 and MSP-2 lipoproteins with phospholipases. When 
[3H]palmitic acid-labeled MSP-1 and MSP-2 were taken up 
in 0.5 M Tris/HC1,  15 mM CaC12, pH 7.5, 10 mM n-otg, 
followed by incubation at 37~  with 200 U of C. atrox phos- 
pholipase A2 for 4 h,  ,u50%  of counts were released into 
the organic phase (Table 1). No further counts were released 
by prolonging the incubation period or increasing the en- 
zyme concentration to 1,000 U. Under similar conditions, 
however, and in contrast to a previous report (22), we were 
unable to obtain release of label from [3H]myristic acid-la- 
beled malarial proteins. The enzymatic cleavage of lipid from 
the acylated protein by phospholipases did not affect the in- 
tegrity of the protein structure as evidenced by the ability 
to detect the intact protein with unaltered strength of signal 
by polyvalent antisera in Western blotting (data not shown). 
In contrast to the membrane from variant surface glyco- 
protein (mfVSG) of T. brucei, the malarial structures  were 
insensitive to PI-PLC from either trypanosomes or Staphylo- 
coccus aureus. In further contrast to the mfVSG GPI (23), 
Table  1.  Chemical and Enzymatic Deacylation of the Highly 
Purified [3HIFatty Acid-labeled MSP-I  and MSP-2 Proteins 
195  56 
Myristic  Palmitic  Myristic  Palmitic 
NaOH  100.5%  100%  104%  97.9% 
PLA2  0.2%  47.5%  2.1%  50.3% 
PIPLC  0%  0.3%  0.9%  0% 
PCPLC  96.2%  ND  99.8%  ND 
After  treatment  with chemicals  or enzymes,  samples  were  extracted  with 
organic solvents, and the percentage  release  of labded fatty  acid was de- 
termined  by scintillation  counting,  as described  in Materials and Methods. 
myristic acid-labeled malarial GPI could be cleaved 100% 
by/~ cereus phospholipase  C.  A previous study has shown 
that/g cereus PLC preparations (Sigma Chemical Co.) con- 
tain predominantly a phosphatidylcholine-specific PLC (23). 
As the/g cereus enzyme is inactive against mfVSG, and the 
malarial  GPI  appears insensitive  to  either  S.  aureus or 
trypanosomal PI-PLCs, the activity we observed may result 
from  a  contaminating PI-PLC  that  discriminates  among 
malarial and trypanosomal GPIs, or from the ability of the 
PC-PLC  itself to deacylate the malarial GPI.  As these en- 
zymes have positional  specificity it is clear from these data 
that the malaria GPI differs from the T. brucei structure. 
Induction of TNF and ILl by MalariaI Antigens and the Purified 
GPI.  To determine whether the GPI-anchored surface an- 
tigens of  parasites were able to induce the production of TNF 
and Ibl from macrophages, highly purified MSP-1 and MSP-2 
were dialyzed exhaustively against RPMI 1640. The absence 
of detergent and cytotoxic agents in the dialyzed samples was 
confirmed by a variety of methods, including incubation  of 
aliquots with viable ceils overnight followed by microscopic 
examination of morphology  and trypan blue exclusion assays. 
The dialyzed  labeled proteins  were added  to  cultures  of 
thioglycollate-elicited peritoneal macrophages from CBA/Ca 
or LPS-hyporesponsive C3H/HeJ mice overnight. The mac- 
rophage supernatants  derived from these incubations  were 
tit'rated further in RPMI 1640 containing 5/~g/ml actinomycin 
D and added to cultures of L929 cells for the determination 
of TNF levels. Low concentrations of purified native pro- 
teins of malaria were able to elicit high levels of TNF from 
macrophages  (Table 2). To ensure that the release of TNF 
from macrophages was not the result  of adventitious  con- 
tamination of the samples or procedure by LPS, a number 
of stringent controls and precautions were undertaken.  For 
example, the LPS-hyporesponsive  mouse strain C3H/HeJ was 
fully able to respond to malarial antigens with the produc- 
tion of TNF (Table 2). In further experiments, 1-ml aliquots 
of purified native MSP-1 and MSP-2 proteins dialyzed against 
tLPMI 1640 were mixed with 100-/xl volumes ofmAbs 111.4 
or 113.1 bound to CNBr-activated Sepharose  (stored routinely 
in sterile RPMI 1640) for 1 h at room temperature, followed 
by microfuge  centrifugation. Immtmoprecipitation of the na- 
tive antigens in this manner reduced by ,x,90% the amount 
of TNF induced by the MSP-1 and MSP-2 preparations (Table 
2). In addition,  as shown below, TNF induction was sensi- 
tive to phospholipases that do not affect LPS. Finally, we have 
observed that polymyxin B, at concentrations  sufficient to 
neutralize high levels of LPS, was unable to inhibit TNF in- 
duction by parasite GPI (data not shown). However, we have 
viewed the use of polymyxin B as an anti-LPS reagent with 
caution, since this antibiotic is a known inhibitor of protein 
kinase C, and in addition we have observed that polymyxin 
B-agarose binds to and precipitates the labeled GPI (data not 
shown). 
sn-1, 2-DiacylglyceroI  Required  for Cytokine Induction.  To test 
the hypothesis that the covalently associated posttranscrip- 
tional glycolipid modification of the native proteins is respon- 
sible for the induction of cytokines by native antigen, native 
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TNF/2  x  10  s macrophages  IL-1/2  x  10  s macrophages 
Agent  1"  2*  3  4  5 
U  pg 
MSP-1  (5  p.g)  282  217  409  137  - 
MSP-1  +  50 mM NaC1  198  .... 
MSP-1  +  50 mM NaOH  0  .... 
MSP-1 immunoprecipitated  12  19  -  -  - 
MSP-1  +  PLA2  -  -  33  -  - 
MSP-1  +  PLC  -  -  -  3  - 
MSP-2  (4.5/zg)  148  186  320  109  251 
MSP-2  +  50 mM NaCI  133  .... 
MSP-2  +  50 mM NaOH  0  .... 
MSP-2 immunoprecipitated  28  22  -  -  66 
MSP-2  +  PLA2  -  -  38  -  38 
MSP-2  +  PLC  -  -  -  0  13 
MSP-2 GPI (250 ng)  408  354  -  -  842 
MSP-2  GPI  +  5  ttM  staurosporine  -  4  -  -  O 
After purification, treatment, and dialysis against R.PMI 1640, antigem were added to 2  x  10s CBA/Ca or C3H/HeJ thioglycolhte-elicited peritoneal 
macrophagas per well. Quantitative  d__0y~'y_  htion of pH]fatty acid-labeled m~h,hl antigens was confirmed by organic solvent extraction of subali- 
quots. Remaining aliquots were dialyzed  ~,~6r  against complete RPM11640 and used in assays  of TNF ~.  Antigem were immunoprtdpitated 
by mixing with 10% by volume of specific  mAbs (111.4 or 113.1) covahafly conjugated to CNBr-activated Sepharose, stored under sterile conditions 
in R.PMI 1640 with 100 t~g/ml Polymyxin B. TNF levels were determined by titration  on L929 cells. 
* Exempt  number. 
* C3H/HeJ macrophages. 
proteins  were  deacylated by a  variety of methods  and  the 
influence of these treatments on the ability of the antigens 
to induce TNF was determined.  Native proteins  subject to 
mild base hydrolysis were unable to induce TNF from mac- 
rophages (Table 2). Similarly, native proteins exposed to PLC 
and  PLA2,  with  quantitative  loss  of the  appropriate  fatty 
acid demonstrated in aliquots by organic solvent extraction, 
lost their TNF-inducing  capability (Table 2).  Thus,  the in- 
tact sn-l,2-diacylglycerol is required for TNF formation. These 
treatments,  however, did not affect the protein structure  of 
the molecules as judged by migration in SDS-PAGE and sen- 
sitivity  to  detection  in  Western  blots by polyclonal  rabbit 
antisera  to  MSP-1  or  a  monoclonal  anti-MSP-2  (data  not 
shown). 
To determine whether the GPI moiety alone was suffident 
to elicit cytokine production from macrophages in vitro, the 
COOH-terminal  GPI fragment was added to macrophages 
in twofold serial dilutions.  This titration revealed the highly 
purified  GPI moiety to be more efficient  in  diciting  both 
TNF  and  II.-1 from macrophages  than  the  native protein- 
GPI complex, when compared on a molar basis (Fig.  3  and 
Table 2). 
Malarial  GPI  Substitutes  for  the  Second  Messenger  of In- 
sulin.  Mammalian glycosylphosphatidylinositol is proposed 
to be the  second  messenger  mediating  signal  transduction 
in response to insulin  (24).  Since hypoglycaemia and hyper- 
triglyceridaemia are common pathophysiological conditions 
associated with both malaria and trypanosome infection, we 
sought to determine whether the malarial GPI is insulin mi- 
metic. GPI-linked surface proteins and the purified GPI were 
Figure 3,  Titration of IL-1 production by the GPI. Various concentra- 
tions of purified MSP-2 GPI and native MSP-2 antigen in tLPMI 1640 
were added to 2  x  10  s thiogl)c,  olhte-elidted peritoneal macrophages  over- 
night  and the level of ILl determined by monoclonal capture ELISA 
(Genzyme). 
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triglyceride  lipogenesis and glucose oxidation by adipocytes, 
similar to that induced by insulin in this and previous (25, 
26) studies (Table 3). As previously reported (25), partial an- 
alognes of GPI such as mannose and inositol monophosphate 
inhibited lipogenesis by insulin. These agents were able to 
a similar degree to block the insulin-mimetic activity of the 
parasite  GPI. 
Pathophysiological Activities  of the GPI In  Viva  To deter- 
mine whether these activities on host cells in vitro can occur 
in  vivo,  thioglycoUat~primed  mice  were  inoculated  in- 
traperitoneally with 12 ~g purified malarial GPI in saline. 
There was a pronounced and prolonged drop in blood glu- 
cose concentration (Hg. 4 A). The animals showed clear signs 
of a transient pyrexia (ruffled fur, cold extremities, listless 
behavior), and occasionally diarrhea, but did not die as a re- 
sult of this treatment. However, the sensitivity of mice to 
the lethal effects of TNF may be markedly increased by ex- 
posure to a variety of bacterial agents, or to D-galactosamine 
(27). This phenomenon has already been used to demonstrate 
the existence of TNF-inducing agents in malarial extracts (11). 
In various experiments between 80 and 100% of mice died 
when receiving malaria GPI 30 min after exposure to D-ga- 
lactosamine, although none died when exposed to either agent 
alone (Fig. 4 B). We wished to determine whether the ob- 
served cachexia and mortality were indeed due to the action 
of TNF, and, since TNF itself may cause a drop in blood 
glucose levels (15), to exclude the possibility that the observed 
Table  3.  Induction of Lipogenesis and Glucose Oxidation by 
the Malarial GPI 
Metabolism of 
[l'C]ghcose 
[l'C]-labeled 
Agent  14CO2  lipids 
None  121  •  19  72  •  8 
Mannose  116  •  8  66  •  10 
IMP  143  _+  24  59  _+ 4 
Insulin (100/~U)  603  •  56  289  _+  17 
Insulin  +  2.5 raM mannose  177  •  9  74  •  11 
Insulin  +  2.5 mM IMP  355  •  46  148  •  30 
MSP-1  498  +  23  204  •  18 
GPI (2.5 /zg)  670  •  72  412  _+  62 
GPI (0.25 /~g)  551  •  15  395  +_  27 
GPI (0.25 /zg) +  2.5 mM mannose  183  +  33  97  +  11 
GPI (0.25 /~g) +  2.5 mM IMP  209  +  29  125  _+  16 
Figure 4.  Malaria  GPI induces  TNF release  and hypoglycaemia  in vivo. 
ThioglycoUate-primed  mice received either PBS alone or 18 mg D-ga- 
lactosamine  in PBS intraperitoneally.  After  30 rain some  received  12.5/tg, 
purified malarial  GPI (time 0). Some  groups also received  250/~g mAb 
TN3.19.12 against routine  TNF (kind  gift of Dr. Schreiber, University 
of Missouri), in 200/~1 PBS intraperitone.ally.  (A) Blood  glucose levels 
were determined  by Rdtolux S blood glucose  meter (Boehringer  Mann- 
heim Diagnostics),  and are expressed  as the change  in blood  glucose  con- 
centration  in mmol/liter + 1  SE (B) In three  separate  experiments,  deaths 
were scored after 48 h. 
hypoglycemia was merely a secondary consequence of TNF 
induction. Accordingly, administration of a TNF-neutralizm"  g 
mAb rescued all or the majority of mice from GPI-induced 
cachexia and death, but did not greatly influence the devel- 
opment of hypoglycaemia (Fig. 4, A  and B). The induction 
of TNF-independent hypoglycemia by extracts of P. ~elii- 
infected and uninfected erythrocytes has recently been re- 
ported elsewhere (28). 
Assays of glucose  metabolism  by adipocytes  in response to insulin,  para- 
site GPI, and inhibitors were carried out as described in Materials and 
Methods. Values shown are the means _+ SE of quadruplicate  determi- 
nations, and are expressed as pmol/10~ ceils (14CO2 production), and 
nmol/10~ cells (14C-labeled  lipids). IMP, inositol monophosphate. 
Discussion 
The GPI molecules linked to surface antigens of the para- 
site are glycolipid toxins diciting several pathophysiological 
responses associated with acute and severe malaria infection, 
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with attendant pyrexia and cachexia. This TNF-mediated tox- 
icity can be lethal in sensitized individuals. Since each of these 
conditions has a counterpart in acute trypanosomiasis, this 
novel pathogenic process may be more widely associated with 
eukaryotic parasitism.  Parasite GPI molecules may also con- 
tribute to other forms of cellular dysfunction found in both 
infections, such as the polyclonal activation of lymphocytes. 
The simplest explanation for our observations  is that para- 
site GPI molecules exert an influence on host cells when 
released during merogony or cell death, by substituting for 
the endogenous second messenger/signal transduction path- 
way, which utilizes glycosylphosphatidylinositol  and its de- 
rivatives  to regulate protein kinase C  and Ca  2+  levels. In 
support of this view induction of both cytokines by the GPI 
requires an intact sn-l,2-diacylglycerol,  and is blocked by the 
PKC inhibitor stanrosporine (Table 2). Our demonstration 
that a single purified GPI species is strongly insulin mimetic 
substantially validates  the proposed (24)  role of inositol- 
phosphoglycans in insulin signal transduction. 
In this study we have concentrated on the mature-form 
GPI assodated with the surface antigens of the parasites, simply 
to ensure the biochemical identity and purity of out mate- 
rial. It should be noted, however, that the parasites may con- 
tain a variety of GPI precursors  and intermediates not in 
association  with proteins (29),  and glycosyl-phosphatidyl- 
inositols of this type, differing in polarity and hydrophilicity 
through the addition of ethanoalamine and sugar groups, may 
actually contribute equally or more than GPI-anchored mem- 
brane proteins to the pathophysiological response of the host 
when released during merogony or cell death. 
We have previously demonstrated that the GPI-anchored 
(30) native circumsporozoite (CS) protein of malaria sporo- 
zoites is a thymus-independent antigen, capable of eliciting 
antibody production from primed B calls alone without a 
requirement for cognate T cell hdp (31). Full-length recom- 
binant protein analogues lacking the GPI anchor, however, 
do not have this ability and behave as typical T-dependent 
protein antigens. This circumstantial evidence has lead us to 
propose that the GPI moiety on the native CS protein con- 
tributes to thymic independence by providing a mitogenic 
or comitogenic signal to B ceils (31, 32).  If this reasoning 
is correct, the malarial GPI might also contribute to the poly- 
donal activation of lymphocytes as a mitogen or comitogen, 
the existence of which in malarial infections was originally 
proposed by Greenwood and Vick (33). 
In keeping with our propositions concerning B cell acti- 
vation and the T independence of the GPI-anchored CS pro- 
rein, we have recently shown that immunization of mice with 
highly purified malaria GPI prepared from the mature MSlX2 
leads to an serological anti-GPI response with T-independent 
features (i.e., IgM dominated and without anamnestic char- 
acteristics). These anti-GPI sera are able even at high titra- 
tion to neutralize TNF induction and lipogenesis by both 
the heterologous MSP-1 antigen and whole parasite extracts 
(our unpublished data).  Although it is not possible  to ex- 
clude the possibility that molecules unrdated to the GPI may 
also contribute to TNF induction and hypoglycaemia in the 
in vivo response to infection, these data support the view 
that the GPI may be the dominant pyrogen/toxin of malaria 
parasites. In addition, the same data raise the possibility that 
antibodies that neutralize the toxic activities  of this mole- 
cule may be acquired after  exposure to parasites  and may 
mediate tolerance or acquired clinical immunity to disease. 
Since these antibodies are apparently T  independent in na- 
ture any clinical immunity they might provide would wane 
fast in the absence of reinfection, as is thought to be the case 
with clinical immunity to malaria. The question of the exis- 
tence of an antitoxic immunity has recently been reviewed 
by Playfair et al. (34). The identification of the GPI molecule 
as a parasite toxin and the development of methods to mea- 
sure an anti-GPI serological response should allow further 
experimental and epidemiological studies to assess the role 
of the GPI and anti-GPI antibodies in both the clinical re- 
sponse and clinical immunity to infection. For example, it 
should be possible in appropriately defined case-control studies 
to determine whether the hyperactive malarial splenomegaly 
and clinically severe  or cerebral malaria syndromes are associated 
with states of physiological hyperresponsiveness to the GPI, 
and correspondingly whether a condition of hyporesponsive- 
hess is assodated with the phenomenon of childhood "toler- 
ance"  to malaria. 
The possibility of devdoping an "anfidisease" vaccine against 
malaria has already been suggested (34). Both high TNF levels 
and hypoglycaemia are associated with poor prognosis in se- 
vere malaria infections (35). Our data raise the prospect of 
providing clinical protection against malarial disease, either 
by passive transfer of neutralizing anti-GPI monodonal or 
polydonal antibodies, or by immunization against the GPI 
or various  nontoxic analogues.  Notwithstanding technical 
problems and the need to avoid autoimmune reactions,  the 
identification of the biochemical nature of this toxin and our 
observations concerning the neutralization of TNF induc- 
tion and lipogenesis by anti-GPI antibodies may help to pro- 
vide a rationale for the development of an antiglycolipid vac- 
cine against malaria. 
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